Exact Mass: 648.4729804

Exact Mass Matches: 648.4729804

Found 73 metabolites which its exact mass value is equals to given mass value 648.4729804, within given mass tolerance error 1.31072E-15 dalton. Try search metabolite list with more accurate mass tolerance error 2.62144E-16 dalton.

PA(16:0/16:0)

2-(Hexadecanoyloxy)-1-[(phosphonooxy)methyl]ethyl hexadecanoate

C35H69O8P (648.4729804)


PA(16:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. Indeed, the concentration of phosphatidic acids is often over-estimated in tissues and biofluids as it can arise by inadvertent enzymatic hydrolysis during inappropriate storage or extraction conditions during analysis. The main biosynthetic route of phosphatidic acid in animal tissues involves sequential acylation of alpha-glycerophosphate by acyl-coA derivatives of fatty acids. PAs are biologically active lipids that can stimulate a large range of responses in many different cell types, such as platelet aggregation, smooth muscle contraction, in vivo vasoactive effects, chemotaxis, expression of adhesion molecules, increased tight junction permeability of endothelial cells, induction of stress fibres, modulation of cardiac contractility, and many others. Diacylglycerols (DAGs) can be converted to PAs by DAG kinases and indirect evidence supports the notion that PAs alter the excitability of neurons. Phospholipase Ds (PLDs), which catalyze the conversion of glycerolphospholipids, particularly phosphatidylcholine, to PAs and the conversion of N-arachidonoyl-phosphatidylethanolamine (NAPE) to anandamide and PAs are activated by several inflammatory mediators including bradykinin, ATP and glutamate. PAs activate downstream signaling pathways such as PKCs and mitogen-activated protein kinases (MAPKs), which are linked to an increase in sensitivity of sensory neurons either during inflammation or in chronic pain models. Circumstantial evidence that PAs are converted to DAGs. (PMID: 12618218, 16185776). [HMDB] PA(16:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. Indeed, the concentration of phosphatidic acids is often over-estimated in tissues and biofluids as it can arise by inadvertent enzymatic hydrolysis during inappropriate storage or extraction conditions during analysis. The main biosynthetic route of phosphatidic acid in animal tissues involves sequential acylation of alpha-glycerophosphate by acyl-CoA derivatives of fatty acids. PAs are biologically active lipids that can stimulate a large range of responses in many different cell types, such as platelet aggregation, smooth muscle contraction, in vivo vasoactive effects, chemotaxis, expression of adhesion molecules, increased tight junction permeability of endothelial cells, induction of stress fibres, modulation of cardiac contractility, and many others. Diacylglycerols (DAGs) can be converted to PAs by DAG kinases and indirect evidence supports the notion that PAs alter the excitability of neurons. Phospholipase Ds (PLDs), which catalyze the conversion of glycerolphospholipids, particularly phosphatidylcholine, to PAs and the conversion of N-arachidonoyl-phosphatidylethanolamine (NAPE) to anandamide and PAs are activated by several inflammatory mediators including bradykinin, ATP and glutamate. PAs activate downstream signaling pathways such as PKCs and mitogen-activated protein kinases (MAPKs), which are linked to an increase in sensitivity of sensory neurons either during inflammation or in chronic pain models. Circumstantial evidence that PAs are converted to DAGs. (PMID: 12618218, 16185776).

   

PA(10:0/22:0)

[(2R)-3-(decanoyloxy)-2-(docosanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(10:0/22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/22:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of behenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:0/14:0)

[(2R)-3-(octadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(18:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:0/14:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(20:0/12:0)

[(2R)-2-(dodecanoyloxy)-3-(icosanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(20:0/12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/12:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of lauric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(22:0/10:0)

[(2R)-2-(decanoyloxy)-3-(docosanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(22:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/10:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/i-22:0)

[(2R)-3-(decanoyloxy)-2-[(20-methylhenicosanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(10:0/i-22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-22:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isodocosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(20:0/i-12:0)

[(2R)-3-(icosanoyloxy)-2-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(20:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/i-12:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/i-24:0)

[(2R)-2-[(22-methyltricosanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(8:0/i-24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-24:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isotetracosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-13:0/i-19:0)

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(17-methyloctadecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(a-13:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-19:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/i-20:0)

[(2R)-2-[(18-methylnonadecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-12:0/i-20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-20:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isoeicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-13:0/i-19:0)

[(2R)-3-[(11-methyldodecanoyl)oxy]-2-[(17-methyloctadecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-13:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-19:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-20:0/12:0)

[(2R)-2-(dodecanoyloxy)-3-[(18-methylnonadecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-20:0/12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/12:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of lauric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-20:0/i-12:0)

[(2R)-3-[(18-methylnonadecanoyl)oxy]-2-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-20:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-20:0/i-12:0), in particular, consists of one chain of isoeicosanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-22:0/10:0)

[(2R)-2-(decanoyloxy)-3-[(20-methylhenicosanoyl)oxy]propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-22:0/10:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-22:0/10:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position and one chain of capric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-24:0/8:0)

[(2R)-3-[(22-methyltricosanoyl)oxy]-2-(octanoyloxy)propoxy]phosphonic acid

C35H69O8P (648.4729804)


PA(i-24:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-24:0/8:0), in particular, consists of one chain of isotetracosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

2,3-Bis(palmitoyloxy)propyl dihydrogen phosphate

2,3-Bis(palmitoyloxy)propyl dihydrogen phosphoric acid

C35H69O8P (648.4729804)


   

1-lauryl-2-arachidyl glycerol-3-phosphate

1-lauryl-2-arachidyl glycerol-3-phosphate

C35H69O8P (648.4729804)


   

PA(16:0/16:0)

1,2-Dipalmitoyl-sn-glycerol 3-phosphate

C35H69O8P (648.4729804)


   

1,2-Dipalmitoyl-sn-glycero-3-phosphate

1,2-Dipalmitoyl-sn-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1,2-Dipalmitoy

2-(Hexadecanoyloxy)-1-[(phosphonooxy)methyl]ethyl hexadecanoate

C35H69O8P (648.4729804)


   

Dipalmitoyl

Hexadecanoic acid, 1-[(phosphonooxy)methyl]-1,2-ethanediyl ester, (R)-

C35H69O8P (648.4729804)


   

PA(20:0/12:0)

1-eicosanoyl-2-dodecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(19:0/13:0)

1-nonadecanoyl-2-tridecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(18:0/14:0)

1-octadecanoyl-2-tetradecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(17:0/15:0)

1-heptadecanoyl-2-pentadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(15:0/17:0)

1-pentadecanoyl-2-heptadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(14:0/18:0)

1-tetradecanoyl-2-octadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(13:0/19:0)

1-tridecanoyl-2-nonadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA(12:0/20:0)

1-dodecanoyl-2-eicosanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

PA 32:0

Hexadecanoic acid, 1-[(phosphonooxy)methyl]-1,2-ethanediyl ester, (R)-

C35H69O8P (648.4729804)


   

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C35H69O8P (648.4729804)


   
   
   
   
   
   
   
   
   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) hexacosanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) hexacosanoate

C35H69O8P (648.4729804)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

C35H69O8P (648.4729804)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C35H69O8P (648.4729804)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C35H69O8P (648.4729804)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C35H69O8P (648.4729804)


   

(1-Pentadecanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Pentadecanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C35H69O8P (648.4729804)


   

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) octadecanoate

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) octadecanoate

C35H69O8P (648.4729804)


   

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) nonadecanoate

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) nonadecanoate

C35H69O8P (648.4729804)


   

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) henicosanoate

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) henicosanoate

C35H69O8P (648.4729804)


   

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C35H69O8P (648.4729804)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] henicosanoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] henicosanoate

C35H69O8P (648.4729804)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] henicosanoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] henicosanoate

C35H69O8P (648.4729804)


   

1,2-dihexadecanoyl-sn-glycerol-3-phosphate

1,2-dihexadecanoyl-sn-glycerol-3-phosphate

C35H69O8P (648.4729804)


A 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is also hexadecanoyl.

   

dihexadecanoyl phosphatidic acid

dihexadecanoyl phosphatidic acid

C35H69O8P (648.4729804)


A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).

   

1-eicosanoyl-2-dodecanoyl-glycero-3-phosphate

1-eicosanoyl-2-dodecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-octadecanoyl-2-tetradecanoyl-glycero-3-phosphate

1-octadecanoyl-2-tetradecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-tetradecanoyl-2-octadecanoyl-glycero-3-phosphate

1-tetradecanoyl-2-octadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-nonadecanoyl-2-tridecanoyl-glycero-3-phosphate

1-nonadecanoyl-2-tridecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-pentadecanoyl-2-heptadecanoyl-glycero-3-phosphate

1-pentadecanoyl-2-heptadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-heptadecanoyl-2-pentadecanoyl-glycero-3-phosphate

1-heptadecanoyl-2-pentadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-tridecanoyl-2-nonadecanoyl-glycero-3-phosphate

1-tridecanoyl-2-nonadecanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

1-dodecanoyl-2-eicosanoyl-glycero-3-phosphate

1-dodecanoyl-2-eicosanoyl-glycero-3-phosphate

C35H69O8P (648.4729804)


   

BisMePA(30:0)

BisMePA(16:0_14:0)

C35H69O8P (648.4729804)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved